Duo-Vil (amitriptyline / perphenazine) Drug Interactions
A total of 1293 drugs (7355 brand and generic names) are known to interact with Duo-Vil (amitriptyline / perphenazine).
- 372 major drug interactions (2585 brand and generic names)
- 845 moderate drug interactions (4137 brand and generic names)
- 76 minor drug interactions (633 brand and generic names)
Check for interactions with Duo-Vil (amitriptyline / perphenazine)
Common medications checked in combination with Duo-Vil (amitriptyline / perphenazine)
- Adderall (amphetamine / dextroamphetamine)
- CoQ10 (ubiquinone)
- Coreg (carvedilol)
- Effexor (venlafaxine)
- Focalin XR (dexmethylphenidate)
- Lexapro (escitalopram)
- Methylin (methylphenidate)
- Paxil (paroxetine)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Strattera (atomoxetine)
- Xanax (alprazolam)
- Zyrtec (cetirizine)
Duo-Vil (amitriptyline / perphenazine) alcohol/food Interactions
There is 1 alcohol/food interaction with Duo-Vil (amitriptyline / perphenazine)
Duo-Vil (amitriptyline / perphenazine) disease Interactions
There are 37 disease interactions with Duo-Vil (amitriptyline / perphenazine) which include:
- Dementia
- Liver Damage
- Acute Alcohol Intoxication
- Cardiovascular Disease
- Cns Depression
- Head Injury
- Anticholinergic Effects
- Cardiovascular Disease
- Pheochromocytoma
- Acute Myocardial Infarction Recovery
- Cardiovascular Disease
- Depression
- Seizure Disorders
- Anticholinergic Effects
- Breast Cancer
- Dystonic Reactions
- Hematologic Toxicity
- Nms
- Parkinsonism
- Renal Dysfunction
- Respiratory Disorders
- Seizure Disorders
- Tardive Dyskinesia
- Bone Marrow Suppression
- Diabetes
- Renal/Liver Disease
- Schizophrenia/Bipolar Disorder
- Tardive Dyskinesia
- Acute Alcohol Intoxication
- Bipolar Disorder Screening
- Glaucoma
- Hyper/Hypoglycemia
- Liver/Renal Disease
- Neutropenia
- Schizophrenia
- Thyroid Disorders
- Urinary Retention
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No information available. |
Do not stop taking any medications without consulting your healthcare provider.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
